HNGE logo

Hinge Health, Inc. Stock Price

NYSE:HNGE Community·US$5.8b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 18 Fair Values set on narratives written by author

HNGE Share Price Performance

US$78.97
32.46 (69.79%)
US$72.00
Fair Value
US$78.97
32.46 (69.79%)
9.7% overvalued intrinsic discount
US$72.00
Fair Value
Price US$78.97
AnalystHighTarget US$72.00
AnalystConsensusTarget US$64.29
AnalystLowTarget US$65.00

HNGE Community Narratives

·
Fair Value US$72 9.7% overvalued intrinsic discount

Expanding Digital MSK Reach And AI Care Tools Will Transform Long-Term Earnings Potential

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$64.29 22.8% overvalued intrinsic discount

AI Adoption And Digital MSK Demand Will Drive Strong Long Term Earnings Power

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value US$65 21.5% overvalued intrinsic discount

AI Efficiency And Engagement Based Pricing Will Shape Musculoskeletal Care Outlook

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
US$72
9.7% overvalued intrinsic discount
Profit Margin
15.75%
Future PE
47.87x
Price in 2029
US$88.15
US$64.29
22.8% overvalued intrinsic discount
Profit Margin
8.93%
Future PE
88.42x
Price in 2028
US$78.66

Trending Discussion

Updated Narratives

HNGE logo

HNGE: Multi Product Expansion Could Struggle To Justify Rich Future Expectations

Fair Value: US$65 21.5% overvalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
HNGE logo

Expanding Digital MSK Reach And AI Care Tools Will Transform Long-Term Earnings Potential

Fair Value: US$72 9.7% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
HNGE logo

AI Adoption And Digital MSK Demand Will Drive Strong Long Term Earnings Power

Fair Value: US$64.29 22.8% overvalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

0 Risks
3 Rewards

Hinge Health, Inc. Key Details

US$646.3m

Revenue

US$122.9m

Cost of Revenue

US$523.4m

Gross Profit

US$1.0b

Other Expenses

-US$511.4m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-6.61
80.98%
-79.12%
0%
View Full Analysis

About HNGE

Founded
2012
Employees
1437
CEO
Daniel Perez
WebsiteView website
www.hingehealth.com

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

Recent HNGE News & Updates

Narrative Update Jun 26

HNGE: Multi Product Expansion Could Struggle To Justify Rich Future Expectations

The analyst fair value estimate for Hinge Health has been revised from $43.40 to $65.00, reflecting higher modeled revenue growth and Street research highlighting confidence in multi-year growth potential, new products such as Surgery and Migraine Care, and continued momentum following recent Investor and Movement conferences. Analyst Commentary Recent Street research on Hinge Health has centered on the company’s expanding product set, revised guidance, and evolving long term targets.

Recent updates

No updates